Technical Description
The present invention relates to a nanoparticle formulation comprising of a polymer stabilized inorganic complex having a chemical formula, (Mx[Ny(C2O4)z]-P).
Problems Addressed
- Limitations of Current Anticoagulants
- Biocompatibility Issues
- Expensive
- Toxicity
- Structural and Functional Constraints
Tech Features
- Stabilized Nano formulations
- Non-Toxic
- Easy to Prepare
- Anti-Clotting Functionality
- Biocompatibility & Thermoformability
- Cost-Effective
- Enhanced Blood Circulation
Target Audience
- Healthcare and Medical Sector
- Pharmaceutical Industry
- Biotechnology Industry
- Regenerative Medicine Sector
- Research and Development
Tech ID: P26-1424 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
